Study of triple therapy for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at the safety and effectiveness of adding a third oral diabetes medicine to your current two-drug combination. It is for adults with type 2 diabetes whose blood sugar is not well controlled on metformin plus one other pill.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have type 2 diabetes
- You have been taking metformin plus a DPP-4 inhibitor or an SGLT-2 inhibitor for at least 8 weeks
- Your recent HbA1c (average blood sugar) is between 7.0% and 10.0%
- You are not pregnant or breastfeeding
- You are not on insulin or a GLP-1 receptor agonist
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding an SGLT2 inhibitor or a TZD medication to your current DPP4 inhibitor treatment can better manage your type 2 diabetes. It may be an option if your blood sugar levels are still too high.
This trial tests a combination of three common diabetes medications (metformin, an SGLT2 inhibitor, and a TZD) to see how well they work together and if they are safe. It may help people with type 2 diabetes who need better blood sugar control.
This trial tests the safety and how the body processes three common diabetes medications (dapagliflozin, linagliptin, and metformin) when taken together. Healthy volunteers are needed to help researchers understand how these drugs work in the body.
This trial is testing a combination of three diabetes medicines (henagliflozin, retagliptin, and metformin) in people newly diagnosed with type 2 diabetes. The goal is to see if this triple therapy works better for controlling blood sugar compared to standard treatments.
This trial is testing if adding a combination of SGLT-2 inhibitor and GLP-1 receptor agonist to metformin can improve blood sugar control in people with type 2 diabetes who are not meeting their goals on metformin alone or with one other pill.
This study tests a new three-medicine combination to help control blood sugar in people newly diagnosed with type 2 diabetes who haven't been treated yet. The goal is to find out if this combination works better than current options.
Hear when a new Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.